This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Analyst Expectations For Sarepta Therapeutics's Future
Sarepta Therapeutics Analyst Ratings
H.C. Wainwright Initiates Sarepta Therapeutics(SRPT.US) With Sell Rating, Announces Target Price $80
Express News | Sarepta Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Sell Rating and Target Price $80
J.P. Morgan Maintains Sarepta Therapeutics(SRPT.US) With Buy Rating, Announces Target Price $197